UNSPSC 41141959: Estrogens (total, nonpregnancy) test system

In this classification, Estrogens (total, nonpregnancy) test system connotes a device used to measure Estrogens (total, nonpregnancy) levels. US FDA regulates Estrogens (total, nonpregnancy) test system under 21 CFR 862.1275 and under FDA product code JMD.

UNSPSC 41141959 Estrogens (total, nonpregnancy) test system is a Commodity code under which state and local governments procure laboratory testing kits, reagents, and certified reference materials for forensic drug analysis, toxicology screening, and public health surveillance. Recent solicitations show purchases of Direct ELISA immunoassay reagent kits for controlled-substance screening, certified drug reference standards for method validation and evidentiary analysis, and diagnostic test systems for communicable disease detection. The issuing bodies span state law enforcement and public health agencies (Texas Department of Public Safety, Texas Health and Human Services Commission, Illinois Department of Financial and Professional Regulation, Florida Department of Law Enforcement), county forensic laboratories (Pinellas County, Florida), and correctional departments (Texas Department of Criminal Justice). A mix of sole-source and competitive procurements appears in the recent record, with forensic applications dominating the activity.

Recent opportunities are concentrated in Texas and Florida. The Texas Department of Public Safety posted an IFB (40526R0008445A, due July 23, 2026) for Direct ELISA reagent kits covering 12 substance classes (cannabinoids, opiates, PCP, amphetamines, barbiturates, methamphetamine, cocaine, benzodiazepines, oxycodone, carisoprodol, zolpidem) with estimated quantities of 3 to 30 units per line item and delivery to the Crime Lab Division in Austin. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, issued an Invitation to Quote (260305ITQ, due April 23, 2026) for 131 line items of certified drug reference standards (ISO/IEC 17025:2017 and ISO 17034:2016 accredited, ≥97% purity) for toxicology and seized-drug analysis, with approximately $49,034 of federal Coverdell Act funding designated for equipment and supplies. The Texas Health and Human Services Commission on behalf of the Department of State Health Services conducted an IFB (HHS0016902v2) for DNA screening kits (QIAxcel and QIAamp products) with responses due January 29, 2026 and historical annual spending of $25,050 to $30,000. An Illinois Department of Financial and Professional Regulation sole-source procurement (27416CMSBOSS4B52271) for RAMP System mosquito testing equipment (West Nile Virus and Dengue test kits) posted May 4, 2026, establishing a joint purchase master contract for multistate government use.